EORTC protocol 05963

First line infusional 5-Fluorouracil, Folinic Acid and Oxaliplatin for metastatic colo-rectal cancer or loco-regional recurrency. Role of chronomodulated delivery upon survival. A multicenter randomized Phase III trial.
Trial StatusAll trial activities ended
DatesDate of activation: 31-Mar-98
Closed on : 01-Mar-02
Data management at EORTCFull
Phase3
Randomized trialYes
TypeAdvanced
Targeted Sample size554
Number of steps1
Drug
Study StaffSylvie Giacchetti (Study Coordinator) - Assistance Publique - Hôpitaux de Paris - Hopital Saint-Louis AP-HP, Paris
Marie-Ange Lentz (Data Manager) - EORTC Headquarters, Brussels
Sandrine Marreaud (Coordinating Physician) - EORTC Headquarters, Brussels
Type of cancerColon
Rectal
Participating GroupsEORTC Chronotherapy Group (closed group)(Coordinating Group)
Protocol summaryCancer.gov (PDQ)
ClinicalTrials.gov
NCT numberNCT00003287
EudraCT
Back to Protocol section